Details
- Status
- Closed
- Opening date
- Deadline
- Department
- Directorate-General for Health and Food Safety
Target audience
Public health community
Why we are consulting
Period of consultation
From 5 July 2013 to 5 November 2013.
Contributions to and results of the consultation
Below are the public responses to the above-mentioned public consultation:
- AEFI - Spanish Association of Pharmacists in Industry
- AESGP - Association of the European Self-Medication Industry
- APIC - Active Pharmaceutical Ingredients Committee
- AQPA - Austrian Qualified Person Association
- BPI - German Pharmaceutical Industry Association e.V
- CEVA Phylaxia Veterinary Biologicals Co. Ltd.
- Pharmaceutical Quality Group of the Chartered Quality Institute
- EAEPC - European Association of Euro-Pharmaceutical Companies
- EFPIA - European Federation of Pharmaceutical Industries and Associations
- EGA - European Generic Medicines Association
- EIGA - European Industrial Gases Association
- EIPG - European Industrial Pharmacists Group
- European QP Association
- GE Healthcare Life Sciences
- GIRP - Groupement International de la Répartition Pharmaceutique
- HEXAL-SANDOZ
- IFAH - Europe-Animal Health Industry
- ISPE - International Society for Pharmaceutical Engineering
- LEEM - Les Entreprises du Médicament
- LFB Biotechnologies
- Mallet, Jean-Denis - Docteur en pharmacie, ancien inspecteur : [1] - [2]
- MPT Pharma
- PHARMIG - Association of the Austrian pharmaceutical industry
- PIGA - Polish Industrial Gases Association
- Ranbaxy Laboratories Ltd.
- SCIENCE PHARMA Poland
- TEVA Pharmaceuticals Europe
The consultation document
The consultation document can be downloaded here.
Protection of personal data
The policy on "protection of individuals with regard to the processing of personal data by the Community institutions" is based on Regulation (EC) N° 45/2001 of the European Parliament and of the Council of 18 December 2000. More information is available here.
Additional information:
Respond to the consultation
The response period for this consultation has ended. Thank you for your input.